Brief: Adocia: First Patient Dosed In Biochaperone Lispro Phase 3 Programme

Adocia SA

09/05/2022 08:22

May 9 (Reuters) - ADOCIA SA  ADOC.PA :
    * ADOCIA ANNOUNCES THE FIRST PATIENT DOSED IN THE
BIOCHAPERONE®
LISPRO PHASE 3 PROGRAM WITH PARTNER TONGHUA DONGBAO
    * FIRST PATIENT WAS DOSED IN THIS LARGE PHASE 3 PROGRAM
ENROLLING
1300 PEOPLE WITH TYPE 1 OR TYPE 2 DIABETES IN 100 CLINICAL
RESEARCH CENTERS ACROSS CHINA
    * FUTURE PAYMENT OF DOUBLE-DIGIT YEARLY ROYALTIES ON SALES
ON
TONGHUA DONGBAO TERRITORIES
    * THIS DEVELOPMENT MILESTONE TRIGGERS PAYMENT OF $5 MILLION
BY
TONGHUA DONGBAO TO ADOCIA
    * A MAXIMUM OF $30 ADDITIONAL MILLION COULD BE TRIGGERED BY
FUTURE
DEVELOPMENT ACHIEVEMENTS UNTIL PRODUCT REGISTRATION

Source text for Eikon:  ID:nBw6mhmdza 
Further company coverage:  ADOC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))